Cytomx analysts
WebMar 30, 2024 · CytomX Therapeutics Stock Performance NASDAQ:CTMX opened at $1.54 on Thursday. The firm's fifty day simple moving average is $2.25 and its 200 day simple moving average is $1.84. CytomX Therapeutics has a twelve month low of $1.17 and a twelve month high of $3.02. Institutional Investors Weigh In On CytomX Therapeutics WebMar 31, 2024 · CytomX Therapeutics, Inc. (CTMX) Stock Price Today, Quote & News Seeking Alpha CTMX CytomX Therapeutics, Inc. Stock Price & Overview 3.73K …
Cytomx analysts
Did you know?
WebCytomX Therapeutics, Inc. (CTMX) Analyst Ratings, Estimates & Forecasts - Yahoo Finance U.S. markets open in 3 hours 21 minutes S&P Futures +19.25(+0.48%) Dow … WebApr 14, 2024 · CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Rating) has received an average rating of "Hold" from the twelve analysts that are covering the firm, Marketbeat …
WebMar 2, 2024 · InvestorsObserveris giving CytomX Therapeutics Inc (CTMX) an Analyst Rating Rank of 15, meaning CTMX is ranked higher by analysts than 15% of stocks. The average price target for CTMX is $3.564 and analyst’s rate the stock as a Buy. Wall Street analysts are rating CTMX a Buy today. WebAnalyst Coverage. CytomX Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding CytomX Therapeutics, … Annual Reports - Analyst Coverage CytomX Therapeutics, Inc. PD-1 Probody™ Therapeutic Anti-tumor Efficacy and Protection Against … CytomX Therapeutics, Inc. 151 Oyster Point Blvd Suite 400 South San Francisco, CA … Mr. Ogden joined CytomX in August of 2024 after a 16-year tenure at Eli Lilly and … SOUTH SAN FRANCISCO, Calif. , March 22, 2024 (GLOBE NEWSWIRE) -- … Stock Information - Analyst Coverage CytomX Therapeutics, Inc. Events and Presentations - Analyst Coverage CytomX Therapeutics, Inc.
WebApr 13, 2024 · This is a summary of recent ratings and recommmendations for CytomX Therapeutics and Stoke Therapeutics, as provided by MarketBeat. CytomX Therapeutics currently has a consensus price target of $3.17, indicating a potential upside of 94.57%. Stoke Therapeutics has a consensus price target of $24.57, indicating a potential upside … WebApr 14, 2024 · CytomX Therapeutics, Inc. (NASDAQ:CTMX– Get Rating) has received an average rating of “Hold” from the twelve analysts that are covering the firm, Marketbeatreports. One equities research...
WebApr 6, 2024 · Find the latest CytomX Therapeutics, Inc. (CTMX) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. …
WebCytomX Therapeutics, Inc. Analyst Report: AbbVie Inc AbbVie, a research-based biopharmaceutical company, was spun off from Abbott Laboratories in January 2013. … grafico smartart power pointWebApr 14, 2024 · The consensus estimate for Apple’s current full-year earnings is $6.05 per share. KeyCorp also issued estimates for Apple’s Q3 2024 earnings at $1.11 EPS, Q4 2024 earnings at $1.48 EPS, FY2024 ... china buffet morse rdWebApr 10, 2024 · CytomX Therapeutics presently has a consensus target price of $3.17, indicating a potential upside of 103.30%. Stoke Therapeutics has a consensus target price of $24.57, indicating a potential ... graficos offroadWebCTMX Stock 12 Months Forecast. Based on 4 Wall Street analysts offering 12 month price targets for CytomX Therapeutics in the last 3 months. The average price target is $2.48 … grafico softwareWebCompany Type For Profit. Phone Number 6503510353. CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies. … graficos intel hd graphicsWebFeb 5, 2024 · When CytomX Therapeutics last reported its balance sheet in September 2024, it had zero debt and cash worth US$236m. Looking at the last year, the company burnt through US$107m. That means it had... graficos new worldWebCytomX Therapeutics Stock (NASDAQ:CTMX), Analyst Ratings, Price Targets, Predictions. Analysts publish ratings and price targets on most stocks. Benzinga tracks … china buffet mount vernon ohio hours